MedPath

Finafta

Finafta Multioral

Approved
Approval ID

cb027ab8-4175-4cc0-a73e-991dfb113df9

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Sep 23, 2025

Manufacturers
FDA

Dextrum Laboratories Inc.

DUNS: 007392322

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Benzocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65852-001
Application NumberM022
Product Classification
M
Marketing Category
C200263
G
Generic Name
Benzocaine
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 23, 2025
FDA Product Classification

INGREDIENTS (9)

BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PEPPERMINT OILInactive
Code: AV092KU4JH
Classification: IACT
PHOSPHORIC ACIDInactive
Code: E4GA8884NN
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
BENZOCAINEActive
Quantity: 7.5 mg in 100 mL
Code: U3RSY48JW5
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/23/2025

label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 2/18/2020

USES

For the temporary relief of occasional minor irritation, pain, sore mouth, pain associated with canker sores or pain due to minor irritation of the mouth and gums cause by dentures or othodontic applicances.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 2/18/2020

Active Ingredients: (%) Purpose

Benzocaine USP 7.5% ................ Oral Anesthetic/Analgesic

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 2/18/2020

**Purpose**

Oral Anesthetic/Analgesic

WARNINGS SECTION

LOINC: 34071-1Updated: 2/18/2020

Warnings: Do not exceed recommended dosage

**Methemoglobinemia warning:**Use of this product may cause mthemoglobinemia, a serious condition that must be treated promptyly because it reduces the amount of oxygen carried in the blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops:

  • pale, gray, or blue colored skin (cyanosis)
  • headache
  • rapid heart rate
  • shortness of breath
  • dizziness or lightheadedness
  • fatigue or lack of enegry

Allegry alert

do not use this product if you have a history of allergy to local anesthetics such as prcaine, butacaine, bezocaine, or other "caine" anesthetics.

Do not use

  • for teething
  • in children under 2 years of age

Consult a doctor promptly if:

sore mouth symptoms do not improve in 7 days, or if irritation, pain, or redness persists or worsens. If sore throat is sever, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 2/18/2020

**Keep Out of reach of children.**In case of accidental overdose, get medical help or contact a Poison
Control Center right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

LOINC: 53414-9Updated: 2/18/2020

**If pregnant or breastfeeding,**ask a health professional before use.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 2/18/2020

DIRECTIONS:

For children over 12 years of age and Adults
• Apply Finafta® MultiOral Spray up to 4 times daily to affected areas of the mouth, gums or mucus membranes (mouth and throat).

  • Allow to remain in place at least 1 minute and then spit out.

• Close bottle tightly after each use.

  • Children under 12 years of age: Do not use.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 2/18/2020

Inactive ingredients:

Benzalkonium chloride, glycerin, methylparaben, peppermint oil, phosphoric acid, propylene glycol, propylparaben and purified water.

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 9/23/2025

QUESTIONS OR COMMENTS?
305-805-3456
Monday-Friday (9 a.m.- 5 p.m. EST)
www.efficientlabs.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Finafta - FDA Drug Approval Details